This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Bristol-Myers Squibb Company
Drug Names(s): BMS488043, 043
Description: BMS-488043 is a novel, oral small-moleculeattachment inhibitor of HIV-1 that blocks viral entry by binding to the viral envelope protein gp120 and preventing it from binding to cellular CD4 receptors.
Additional information available to subscribers only: